Research With Retinal Cells Derived From Stem Cells for Myopic Macular Degeneration

NCT02122159 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study to be revised. Future plans to be determined.

Conditions

Myopic Macular Degeneration

Interventions

BIOLOGICAL: MA09-hRPE Cellular Therapy

Sponsor

University of California, Los Angeles

Collaborators

[object Object]